Collegium Pharmaceutical (COLL) Interest Expenses (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Interest Expenses of $91.1 million for Q1 2026, little changed year-over-year from $91.1 million in Q1 2025, and up 372.29% quarter-over-quarter from $19.3 million in Q4 2025.
Collegium Pharmaceutical (COLL) Interest Expenses (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Interest Expenses history runs 13 years deep, the most recent figure standing at $91.1 million for Q1 2026.
- In Q1 2026, Interest Expenses changed 0.0% year-over-year to $91.1 million; the TTM figure through Mar 2026 stood at $91.1 million (changed 0.0% YoY), while the FY2025 annual figure was $110.9 million, up 49.86% from the prior year.
- Interest Expenses for Q1 2026 stood at $91.1 million, up from $19.3 million in the prior quarter.
- The five-year high for Interest Expenses was $91.1 million in Q3 2024, with the low at $15.6 million in Q2 2024.
- The 5-year median for Interest Expenses is $22.7 million (2024), against an average of $52.1 million.
- The sharpest annual moves came in 2022 and 2023: Interest Expenses soared 1381.45% in 2022, then plunged 74.99% in 2023.
- Collegium Pharmaceutical's Interest Expenses stood at $20.6 million in 2022, then fell by 6.29% to $19.3 million in 2023, then gained by 17.49% to $22.7 million in 2024, then dropped by 14.84% to $19.3 million in 2025, then soared by 372.29% to $91.1 million in 2026.
- Business Quant data shows COLL's Interest Expenses at $91.1 million in Q1 2026, $19.3 million in Q4 2025, and $91.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Collegium Pharmaceutical | 897.54 Mn | 748.22 Mn | 110.29 Mn | 19.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.68 Mn |
| Jun 30, 2026 | 145.68 Mn |
| Mar 31, 2026 | 91.11 Mn |
| Mar 31, 2026 | 91.11 Mn |
| Dec 31, 2025 | 19.29 Mn |
| Dec 31, 2025 | 19.29 Mn |
| Sep 30, 2025 | 91.11 Mn |
| Sep 30, 2025 | 91.11 Mn |
| Jun 30, 2025 | 91.11 Mn |
| Jun 30, 2025 | 91.11 Mn |
| Mar 31, 2025 | 91.11 Mn |
| Mar 31, 2025 | 91.11 Mn |
| Dec 31, 2024 | 22.65 Mn |
| Dec 31, 2024 | 22.65 Mn |
| Sep 30, 2024 | 91.11 Mn |
| Sep 30, 2024 | 91.11 Mn |
| Jun 30, 2024 | 15.59 Mn |
| Jun 30, 2024 | 15.59 Mn |
| Mar 31, 2024 | 17.47 Mn |
| Mar 31, 2024 | 17.47 Mn |